Cancer Treatment Centers of America


The trade name for sorafenib, Nexavar® is an oral chemotherapy drug. Nexavar® is used for the treatment of advanced renal cell carcinoma (RCC), or kidney cancer, and unresectable hepatocellular carcinoma (HCC), or liver cancer. A multikinase inhibitor, Nexavar® works by targeting two specific receptors, RAF kinase and VEGF receptors, which are responsible for cell division and growth, and angiogenesis (the development of new blood vessels). Thus, Nexavar® interferes with cell communication to help prevent tumor growth.

Our results

our treatment results

View our patient survival rates, along with quality of life, patient experience and quality and patient safety results.

See what CTCA is like

see what ctca is like

Learn about what to expect from your initial consultation through treatment at CTCA.

A team of cancer experts

an expert team just for you

At CTCA, you will be cared for by a team of experienced oncologists and other cancer experts.